bpc-157 tga australia RACGP bpc-157 tga approved australia BPC-157

Key takeaways [54:30]

TB-500s role in tissue regeneration, angiogenesis, and cytoprotection drives interest in comparing oral (capsule), parenteral (injection), and intranasal (spray) methodologies within controlled lab conditions

BPC-157 upregulates VEGF (vascular endothelial growth factor) in tendon tissue, which drives the formation of new capillaries that deliver oxygen and nutrients to a repair site that was effectively starved of vascular support

Injections allow your body to receive the vitamin directly, providing a reliable method to restore and maintain healthy levels

Most clients head straight back to work, errands, the gym or a round of golf